# Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix

> **NCT01365156** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 28 (actual)

## Conditions studied

- Cervical Squamous Cell Carcinoma
- Adenosquamous Carcinoma
- Adenocarcinoma
- Locally Advanced Malignant Neoplasm
- Cervical Cancer

## Interventions

- **PROCEDURE:** Extraperitoneal laparoscopic lymphadenectomy (EPLND)
- **RADIATION:** Chemoradiation

## Key facts

- **NCT ID:** NCT01365156
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2020-01-24
- **Final completion:** 2020-01-24
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01365156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01365156, "Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01365156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*